Second Leading Independent Proxy Advisory Firm Supports Medison and Recommends Change and a New Strategy at Knight Therapeutics
PETACH TIKVA, Israel--(BUSINESS WIRE)--Apr 26, 2019--Medison Biotech (1995) Ltd. (" Medison "), which together with its affiliates owns more than 10.4 million shares or 7.3% of Kni…
